Chemical Compound

(3R,5R)-3,5-Dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (ssR,dR,1S,2R,3S,8S,8aR)-; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S-[1a(ssS*,dS*),2a,3ss,8ss(R*),8aa]]- (9CI); Sodium (ssR,dR,1S,2R,3S,8S,8aR)-1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoate; Pravastatin Related Compound A (USP); 3a-Hydroxy Pravastatin sodium salt; 3a-Hydroxypravastatin sodium salt

CAS Registry Number 81093-43-8
返回搜索 申请报价
(3R,5R)-3,5-Dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (ssR,dR,1S,2R,3S,8S,8aR)-; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S-[1a(ssS*,dS*),2a,3ss,8ss(R*),8aa]]- (9CI); Sodium (ssR,dR,1S,2R,3S,8S,8aR)-1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoate; Pravastatin Related Compound A (USP); 3a-Hydroxy Pravastatin sodium salt; 3a-Hydroxypravastatin sodium salt 结构式
Primary record

(3R,5R)-3,5-Dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (ssR,dR,1S,2R,3S,8S,8aR)-; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S-[1a(ssS*,dS*),2a,3ss,8ss(R*),8aa]]- (9CI); Sodium (ssR,dR,1S,2R,3S,8S,8aR)-1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoate; Pravastatin Related Compound A (USP); 3a-Hydroxy Pravastatin sodium salt; 3a-Hydroxypravastatin sodium salt

库存
8,241 克
纯度
99.5 %
CAS
81093-43-8

化合物标识与属性

CAS
81093-43-8
PubChem CID
45039495
SMILES
CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@H]([C@@H]([C@@H]([C@@H]12)CC[C@H](C[C@H](CC(=O)[O-])O)O)C)O.[Na+]
Canonical SMILES
CC[C@H](C)C(=O)O[C@H]1CC=CC2=C[C@@H](O)[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)[O-])[C@H]21.[Na+]

名称与同义词

  • 3'alpha-Isopravastatin sodium
  • Pravastatin (sodium)
  • Pravastatin related compound A
  • UNII-TC279YC5KM
  • TC279YC5KM
  • 3|A-iso-Pravastatin
  • 81093-43-8
  • 3'alpha-Isopravastatin
  • 3alpha-Hydroxy Pravastatin Sodium Salt
  • CS-514 (sodium)
  • RefChem:90540
  • C23H35NaO7
  • Pravastatin related compound A [USP]
  • 3alpha-Hydroxy pravastatin sodium
  • 6-alpha hydroxy iso compactin
  • DTXSID20230887
  • 3/'alpha-Isopravastatin sodium
  • Pravastatin related compound A RS [USP]
  • CTK8F5221
  • DTXCID50153378
  • 3alpha-Isopravastatin Sodium Salt
  • 3-Hydroxy Pravastatin Sodium Salt
  • 3|A-Hydroxy pravastatin (sodium)
  • 3a-Hydroxy Pravastatin Sodium Salt
  • 3?-Hydroxy Pravastatin Sodium Salt
  • Pravastatin USP Related Compound A
  • USP Pravastatin Related Compound A
  • 3'.ALPHA.-ISOPRAVASTATIN SODIUM
  • 3alpha-Hydroxy pravastatin (sodium)
  • 3|A-Hydroxy Pravastatin Sodium Salt
  • MFCD08063693
  • Pravastatin related compound A (USP)
  • AKOS030242835
  • IH24094
  • 3-Alpha-hydroxy pravastatin sodium salt
  • 3-Alpha Hydroxy Pravastatin Sodium Salt
  • 3 alpha -Hydroxy Pravastatin Sodium Salt
  • DA-49635
  • Pravastatin related compound A RS (USP)
  • PRAVASTATIN RELATED COMPOUND A [USP-RS]
  • Pravastatin sodium,white crystalline powder
  • HY-136347
  • CS-0128386
  • Pravastatin Related Compound A (Sodium Salt)
  • H36146
  • PRAVASTATIN RELATED COMPOUND A (USP-RS)
  • PRAVASTATIN RELATED COMPOUND A [USP IMPURITY]
  • Pravastatin USP related compound A Sodium salt
  • A1038574
  • PRAVASTATIN RELATED COMPOUND A (USP IMPURITY)
  • Q27289890
  • 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-beta,delta,3-trihydroxy-2-methyl-8-((2S)-2-methyl-1-oxobutoxy)-, sodium salt (1:1), (betaR,deltaR,1S,2R,3S,8S,8aR)-
  • 1-NAPHTHALENEHEPTANOIC ACID, 1,2,3,7,8,8A-HEXAHYDRO-.BETA.,.DELTA.,3-TRIHYDROXY-2-METHYL-8-((2S)-2-METHYL-1-OXOBUTOXY)-, SODIUM SALT (1:1), (.BETA.R,.DELTA.R,1S,2R,3S,8S,8AR)-
  • sodium;(3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • (|AR,|AR,1S,2R,3S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-|A,|A,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic Acid Sodium Salt
  • (3R,5R)-3,5-Dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, sodium salt (1:1), (ssR,dR,1S,2R,3S,8S,8aR)-; 1-Naphthaleneheptanoic acid, 1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, monosodium salt, [1S-[1a(ssS*,dS*),2a,3ss,8ss(R*),8aa]]- (9CI); Sodium (ssR,dR,1S,2R,3S,8S,8aR)-1,2,3,7,8,8a-hexahydro-ss,d,3-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoate; Pravastatin Related Compound A (USP); 3a-Hydroxy Pravastatin sodium salt; 3a-Hydroxypravastatin sodium salt
  • 81131-70-6
  • Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]heptanoate
  • sodium,(3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate
  • sodium;(3R,5R)-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,3,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoate